Luke Roush co-founded Sovereign’s Capital in 2012, and is a Managing Partner for both Funds 1 and 2. While living in Kuala Lumpur and Jakarta from 2013-2016, he opened the fund’s operations in Southeast Asia. Luke is primarily focused on the fund’s healthcare and consumer product investments. Prior to Sovereign’s Capital, Luke had twelve years of experience in global commercialization and business development at venture-backed and Fortune 500 companies. He was Vice President for Commercial Operations at TransEnterix, a medical device company that developed and commercialized a minimally invasive surgical system in the US, Europe, and Middle East. Prior to joining TransEnterix, he served as Chief Operating Officer at Liquidia Technologies, a nanotechnology company focused on biopharmaceutical applications. During his tenure at TransEnterix and Liquidia, the companies raised more than $100M in debt and venture capital to drive product development and commercialization. Mr. Roush previously served as global marketing manager for Boston Scientific’s neurovascular stroke business, and held sales and marketing leadership roles at Newell Rubbermaid. He also co-founded 410 Medical, a medical device company focused on pediatric trauma, in 2012. Mr. Roush graduated summa cum laude from Duke University, and earned his MBA from The Fuqua School of Business. Mr. Roush resides in San Jose, California with his wife, Brooke, and their three children.